| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,295 | 24,491 | 21,690 | 20,847 | | Cost of Revenue | 7,150 | 7,667 | 7,010 | 7,078 | | | Gross Profit | 15,145 | 16,825 | 14,680 | 13,769 | | | Operating Expenses | | Research Development | 1,886 | 1,717 | 1,940 | 1,419 | | Selling General and Administrative | 14,264 | 15,205 | 13,112 | 13,020 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,004) | (97) | (372) | (670) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34 | 75 | 135 | 195 | | Earnings Before Interest And Taxes | (971) | (22) | (238) | (475) | | Interest Expense | 756 | 662 | 924 | 801 | | Income Before Tax | (1,727) | (684) | (1,162) | (1,276) | | Income Tax Expense | 14 | 14 | 14 | (53) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,741) | (698) | (1,176) | (1,223) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,741) | (698) | (1,176) | (1,223) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,741) | ($698) | ($1,176) | ($1,223) |
|
0.11% Nasdaq 
0.01%
Income Statement
